Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 2,025,000 | 2,074,000 | 2,010,000 | 2,002,000 | 1,978,000 |
| Cost of Goods | 629,000 | 630,000 | 607,000 | 630,000 | 655,000 |
| Gross Profit | 1,396,000 | 1,444,000 | 1,403,000 | 1,372,000 | 1,323,000 |
| Operating Expenses | 1,345,000 | 1,169,000 | 1,392,000 | 3,788,000 | 1,295,000 |
| Operating Income | 51,000 | 275,000 | 11,000 | -2,416,000 | 28,000 |
| Interest Expense | 91,000 | 92,000 | 102,000 | 107,000 | 112,000 |
| Other Income | -4,000 | -3,000 | -6,000 | -2,000 | 16,000 |
| Pre-tax Income | -44,000 | 180,000 | -97,000 | -2,525,000 | -68,000 |
| Income Tax | 50,000 | 22,000 | -84,000 | -143,000 | 6,000 |
| Net Income Continuous | -94,000 | 158,000 | -13,000 | -2,382,000 | -74,000 |
| Net Income | $-94,000 | $158,000 | $-13,000 | $-2,382,000 | $-74,000 |
| EPS Basic Total Ops | -0.06 | 0.10 | -0.01 | -1.61 | -0.04 |
| EPS Basic Continuous Ops | -0.06 | 0.10 | -0.01 | -1.59 | -0.05 |
| EPS Diluted Total Ops | -0.06 | 0.10 | -0.01 | -1.60 | -0.04 |
| EPS Diluted Continuous Ops | -0.06 | 0.10 | -0.01 | -1.59 | -0.05 |
| EBITDA(a) | $51,000 | $275,000 | $11,000 | $-2,416,000 | $28,000 |